These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 32905641)
1. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells. Qian S; Fang H; Zheng L; Liu M J Biochem Mol Toxicol; 2021 Jan; 35(1):e22611. PubMed ID: 32905641 [TBL] [Abstract][Full Text] [Related]
2. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889 [TBL] [Abstract][Full Text] [Related]
3. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling. Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846 [TBL] [Abstract][Full Text] [Related]
4. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Zhou ZW; Li XX; He ZX; Pan ST; Yang Y; Zhang X; Chow K; Yang T; Qiu JX; Zhou Q; Tan J; Wang D; Zhou SF Drug Des Devel Ther; 2015; 9():1511-54. PubMed ID: 25834399 [TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Cai F; Zhang Y; Li J; Huang S; Gao R Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440 [TBL] [Abstract][Full Text] [Related]
7. [Xihuang Pills and its main components inhibit PI3K/Akt/mTOR signaling pathways and promote the apoptosis of prostate cancer cells in PC-3 tumor-bearing mice]. Long Y; Wu YR; Guo YM; Luo XJ; Li XF; Huang TT; Huang Z; Liu Z; Chen ZJ; Zhou Q; Tian XF Zhonghua Nan Ke Xue; 2021 Apr; 27(4):340-346. PubMed ID: 34914218 [TBL] [Abstract][Full Text] [Related]
8. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559 [TBL] [Abstract][Full Text] [Related]
9. NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways. Yu P; Ye L; Wang H; Du G; Zhang J; Zhang J; Tian J Tumour Biol; 2015 Mar; 36(3):2143-53. PubMed ID: 25398692 [TBL] [Abstract][Full Text] [Related]
10. [Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway]. You XJ; Wen Z; Zheng QX; Li QX; Fu W; Li HS; Wang B Zhonghua Nan Ke Xue; 2023 Dec; 29(12):963-972. PubMed ID: 38639947 [TBL] [Abstract][Full Text] [Related]
11. Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells. Yu Z; Chen Y; Liang C Med Sci Monit; 2019 Nov; 25():8534-8543. PubMed ID: 31714902 [TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells. Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418 [TBL] [Abstract][Full Text] [Related]
13. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Guo Z; Hu X; Xing Z; Xing R; Lv R; Cheng X; Su J; Zhou Z; Xu Z; Nilsson S; Liu Z Mol Cell Biochem; 2015 Aug; 406(1-2):111-9. PubMed ID: 25957503 [TBL] [Abstract][Full Text] [Related]
14. Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis. Qiao S; Zhang W; Jiang Y; Su Y J Mol Histol; 2023 Dec; 54(6):645-654. PubMed ID: 37740843 [TBL] [Abstract][Full Text] [Related]
15. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Pungsrinont T; Kallenbach J; Baniahmad A Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681745 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells. Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116 [TBL] [Abstract][Full Text] [Related]
17. Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway. Fang J; Zhu H; Xu P; Jiang R J Recept Signal Transduct Res; 2022 Aug; 42(4):409-417. PubMed ID: 34645355 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144. Liu J; Xie S; Wu Y; Xu M; Ao C; Wang W; Zeng Q; Hu W; Li M Anticancer Drugs; 2016 Mar; 27(3):156-63. PubMed ID: 26645890 [TBL] [Abstract][Full Text] [Related]
19. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529 [TBL] [Abstract][Full Text] [Related]
20. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling. Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Valeriote FA; Gautam SC J Exp Ther Oncol; 2016 Nov; 11(4):251-260. PubMed ID: 27849335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]